Literature DB >> 21741117

Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN.

A G Venier1, D Gruson, T Lavigne, P Jarno, F L'hériteau, B Coignard, A Savey, A M Rogues.   

Abstract

Pseudomonas aeruginosa is an important pathogen of complicated pneumonia in intensive care units (ICUs). Our objective was to determine 'patient' and 'ward' risk factors for P. aeruginosa pneumonia among patients with nosocomial pneumonia in ICU. Data from the 2004-2006 prospective French national nosocomial infection surveillance in ICUs (REA-RAISIN) were used, including patients admitted for >48 h in ICU and who developed nosocomial pneumonia. Only first pneumonia was considered and categorised as either P. aeruginosa pneumonia or other micro-organism pneumonia. Multilevel logistic regression model (patient as first level and ward as second) with P. aeruginosa pneumonia as binary outcome was performed. Of 3,837 included patients from 201 different wards, 25% had P. aeruginosa pneumonia. P. aeruginosa was significantly more frequent in late onset pneumonia. Higher probability of P. aeruginosa pneumonia was associated with higher age and length of mechanical ventilation, antibiotics at admission, transfer from a medical unit or ICU, and admission in a ward with higher incidence of patients with P. aeruginosa infections. Lower probability of P. aeruginosa was associated with traumatism and admission in a ward with high patient turnover. Our analyses identified a patient's profile and some ward elements that could make suspect P. aeruginosa in case of nosocomial pneumonia.
Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21741117     DOI: 10.1016/j.jhin.2011.05.007

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  19 in total

1.  Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century.

Authors:  Jordi Rello; Bárbara Borgatta; Thiago Lisboa
Journal:  Intensive Care Med       Date:  2013-10-22       Impact factor: 17.440

2.  Age-related differences in the neutrophil response to pulmonary pseudomonas infection.

Authors:  Michael M Chen; Jessica L Palmer; Timothy P Plackett; Cory R Deburghgraeve; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2014-01-05       Impact factor: 4.032

3.  Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.

Authors:  Mohammed J Al-Jaghbeer; Julie Ann Justo; William Owens; Joseph Kohn; P Brandon Bookstaver; Jennifer Hucks; Majdi N Al-Hasan
Journal:  Infection       Date:  2018-05-11       Impact factor: 3.553

4.  Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.

Authors:  Mario Tumbarello; Gennaro De Pascale; Enrico Maria Trecarichi; Teresa Spanu; Federica Antonicelli; Riccardo Maviglia; Mariano Alberto Pennisi; Giuseppe Bello; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2013-02-01       Impact factor: 17.440

5.  Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia.

Authors:  Oliver H Robak; Markus M Heimesaat; Andrey A Kruglov; Sandra Prepens; Justus Ninnemann; Birgitt Gutbier; Katrin Reppe; Hubertus Hochrein; Mark Suter; Carsten J Kirschning; Veena Marathe; Jan Buer; Mathias W Hornef; Markus Schnare; Pascal Schneider; Martin Witzenrath; Stefan Bereswill; Ulrich Steinhoff; Norbert Suttorp; Leif E Sander; Catherine Chaput; Bastian Opitz
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

6.  Antibiotic therapy-induced collateral damage: IgA takes center stage in pulmonary host defense.

Authors:  Juergen Lohmeyer; Rory E Morty; Susanne Herold
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

7.  Bacterial infection in elderly nursing home and community-based patients: a prospective cohort study.

Authors:  J Videcnik Zorman; L Lusa; F Strle; V Maraspin
Journal:  Infection       Date:  2013-04-30       Impact factor: 3.553

8.  Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis.

Authors:  Yanyan Qu; Tolani Olonisakin; William Bain; Jill Zupetic; Rebecca Brown; Mei Hulver; Zeyu Xiong; Jesus Tejero; Robert Mq Shanks; Jennifer M Bomberger; Vaughn S Cooper; Michael E Zegans; Hyunryul Ryu; Jongyoon Han; Joseph Pilewski; Anuradha Ray; Zhenyu Cheng; Prabir Ray; Janet S Lee
Journal:  JCI Insight       Date:  2018-02-08

9.  Management of Pseudomonas aeruginosa pneumonia: one size does not fit all.

Authors:  Jordi Rello; Bárbara Borgatta; Leonel Lagunes
Journal:  Crit Care       Date:  2014-04-29       Impact factor: 9.097

10.  Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.

Authors:  Mehrdad Behnia; Sharon C Logan; Linda Fallen; Philip Catalano
Journal:  BMC Res Notes       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.